Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, raised $100 million in capital from Perceptive Advisors, a life sciences investment firm, to support future company growth. The latest financing brings Kindbody’s total equity and debt funding to more than $290 million, and its valuation to $1.8 billion, solidifying its position as the largest women-owned fertility company serving employers and consumers. This financing allows the company to continue to execute on its vision of affordable and accessible fertility care, by adding new clinics in underserved U.S. markets and by investing in operations to further enhance its care model which is designed to deliver industry-leading clinical outcomes.
“Infertility is widespread, more common than diseases like cancer or diabetes. Yet, for far too long, high-quality fertility care has been available to only a privileged few,” Gina Bartasi, founder and chairwoman of Kindbody, said. “With the support of Perceptive Advisors, and our other investors, Kindbody is positioned to deliver on our vision to help everyone realize their dream of becoming a parent by making high-quality fertility care affordable and accessible for all. In 2023, Kindbody will sharpen its operations, make strategic acquisitions, and maintain our laser focus on profitable growth.”
Kindbody has grown in the past year. In 2022, the company added 42 large employer clients, including Walmart, and today is the fertility benefits provider for 112 companies, covering more than 2.4 million lives. The company also made three strategic acquisitions to accommodate growth. Today, Kindbody owns and operates 31 clinics nationwide with plans to open ten new clinics in 2023 in underserved markets with the greatest demand for affordable, high-quality fertility healthcare.
“This team is unstoppable in their vision to reinvent fertility healthcare,” Sam Chawla, portfolio manager at Perceptive, said. “Kindbody’s differentiated care delivery model, focused on exceptional patient experience and outcomes at a reduced cost for employers and patients, positions it to meet the urgent need for better fertility healthcare solutions, making Kindbody an attractive opportunity for us.”
